rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Soligenix, Inc.

SNGX · Nasdaq

Health CareBiotechnologyNot moving yet

SNGX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 37.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
14 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$19KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders14+0 on the quarter
New · exited5 · 4
Reported value$347K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CITADEL ADVISORS LLCnew · filed 14 Aug 2026209,507$83K+209,507
JANE STREET GROUP, LLCnew · filed 14 Aug 2026207,492$82K+207,492
XTX Topco Ltdadded · filed 14 Aug 2026157,119$62K+136,320+655.4%
GEODE CAPITAL MANAGEMENT, LLCunchanged · filed 12 Aug 2026120,267$48K00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202681,005$32K+22,605+38.7%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202653,914$21K00.0%
NORTHERN TRUST CORPnew · filed 13 Aug 202638,046$15K+38,046
MORGAN STANLEYunchanged · filed 13 Aug 20263,592$1,42200.0%
MERCER GLOBAL ADVISORS INCnew · filed 11 Aug 20263,001$1,188+3,001
JONES FINANCIAL COMPANIES LLLPadded · filed 14 Aug 20261,236$507+1,136+1136.0%
30 Jun 2024 – 30 Jun 2026
71420Jun 24Dec 24Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Anthony Gregg Lapointe Company insiderDirector · last 12 Oct 20261 · 0
Christopher J. Schaber Company insiderCHAIRMAN, CEO AND PRESIDENT · last 12 Oct 202616 · 0
Diane L. Parks Company insiderDirector · last 12 Oct 20261 · 0
Jerome B. Zeldis Company insiderDirector · last 12 Oct 20266 · 1
Jonathan L. Guarino Company insiderCFO · last 12 Oct 20262 · 0
Oreola Donini Company insiderCSO · last 12 Oct 20260 · 0
Robert J. Rubin Company insiderDirector · last 12 Oct 20262 · 0
Richard Straube Company insiderCMO (Consulting) · last 11 Dec 20251 · 0
Timothy R. Cote Company insiderDirector · last 3 May 20230 · 0
Mark E. Pearson Company insiderDirector, 10% owner · last 6 Sep 20191 · 0
Karen R. Krumeich Company insiderSVP and CFO · last 13 Dec 20180 · 0
Keith L. Brownlie Company insiderDirector · last 27 Sep 20181 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 24 Mar 20262.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.9M
Free cash flowFY 2025 · to 31 Dec 2025−$10.3M

Analyst forecasts

No analyst forecasts yet.